Background: Nonadherence to statins limits the benefits of this common drug class.
Individual studies assessing predictors of nonadherence haue produced inconsistent …

Purpose Lipid-lowering medications are often prescribed to decrease the risk of micro-and
macro-cardiovascular complications related to dyslipidaemia. Despite widespread …

Background Nonadherence to chronic disease medications is important. A growing body of
literature suggests that better delivery of established therapies would save more lives than …

Purpose Statins are potent drugs for reducing cholesterol and cardiovascular disease;
however, their effectiveness is significantly compromised by poor adherence. This …

Poor adherence to statin therapy is linked to significantly increased risk of cardiovascular
events and death. Unfortunately, adherence to statins is far from optimal. This is an alarming …

BACKGROUND: Significant disparities exist in cardiovascular outcomes based on
race/ethnicity and gender. Rates of evidence-based medication use and long-term …

Background: Hypercholesterolemia is a major risk factor for atherosclerosis and
cardiovascular disease, the leading cause of death worldwide. In the last twenty years …

Context: Nonadherence to statin therapy is associated with poor cardiovascular outcomes.
Objective: We explored factors and perceptions that contribute to statin therapy …

Introduction Previous research has shown that statin adherence for the primary prevention of
CVD is lower compared to secondary prevention populations. Therefore the aim of this …

Objective: Statins have been shown to reduce the risk of major cardiovascular disease. We
recognize that there is a major gap between the use of statins in actual practice and …